Figure 1: Titers of the peroxiredoxin-2 (Prx2)-specific IgA, IgG, and IgM antibodies in patients with Kawasaki Disease (KD). Serum samples diluted 1:200 were reacted with Prx2. The numbers in parentheses indicate the percentages of anti-Prx2 IgG-, anti-Prx2 IgM-, or anti-Prx2 IgA-positive serum samples in KD patients and control individuals. The dotted line indicates the 100 AU cutoff lines. Open circles represent the cases with Coronary Artery Lesions (CALs). Fisher’s exact test was conducted for comparison of frequency of anti-Prx2 antibodies between the control and KD groups.